Testosterone Enanthate Cost in Michigan (2026): Cash, Insurance, and Compounded Pricing

At a glance
- Average Michigan cash-pay price / $70 per month (2026)
- Manufacturer list price / approximately $120 per month
- Compounded (503A pharmacy) price / around $80 per month
- Michigan Medicaid / covered with prior authorization
- Dose form / intramuscular injection, typically once weekly
- Prescription status / prescription only (Schedule III controlled substance)
- Telehealth prescribing in Michigan / permitted under state law
- Common dose range / 100 to 200 mg per week for TRT
- FDA classification / approved for male hypogonadism
- Savings programs / manufacturer coupons and GoodRx-type discount cards available
What Does Testosterone Enanthate Actually Cost in Michigan Right Now?
The average cash-pay price for testosterone enanthate at Michigan retail pharmacies in 2026 is approximately $70 per month for a standard TRT dose of 200 mg/mL in a 1 mL vial administered weekly. This figure reflects generic pricing. Brand-name formulations carry a manufacturer list price near $120 per month.
Prices vary by pharmacy. A CVS in Detroit may charge differently than an independent pharmacy in Grand Rapids. The 10 mL multi-dose vial (200 mg/mL), which provides roughly 8 to 10 weeks of therapy depending on prescribed dose, typically offers better per-dose economics than single-dose vials. Patients paying cash should ask their pharmacist about multi-dose vial pricing before filling.
The Endocrine Society's 2018 clinical practice guideline recommends testosterone therapy for men with symptomatic hypogonadism confirmed by two morning serum testosterone measurements below 300 ng/dL 1. That threshold matters for cost because insurance coverage, including prior authorization approval, hinges on meeting it.
Michigan ranks among the more affordable states for generic testosterone enanthate. Nationally, cash-pay prices range from $40 to $130 per month depending on region and pharmacy 2. The state's competitive pharmacy market, with major chains and a strong independent pharmacy network, keeps prices closer to the lower end of that spectrum.
Michigan Medicaid Coverage for Testosterone Enanthate
Michigan Medicaid covers testosterone enanthate for the diagnosis of male hypogonadism, but requires prior authorization (PA). The PA process demands documented clinical evidence: two separate morning total testosterone levels below 300 ng/dL, signs or symptoms consistent with androgen deficiency, and exclusion of reversible causes such as opioid use or obstructive sleep apnea.
Processing typically takes 3 to 5 business days. Denials can be appealed. The prescribing provider must submit lab results and clinical notes directly to the Michigan Department of Health and Human Services pharmacy benefits administrator. Once approved, the PA remains valid for 12 months before requiring renewal.
"Testosterone therapy is indicated for men with consistently low testosterone concentrations and associated signs and symptoms," according to the Endocrine Society's guideline document 1. This language maps directly onto what Michigan Medicaid reviewers look for when adjudicating PA requests.
For Medicaid enrollees who receive approval, the out-of-pocket cost is minimal. Copays under Michigan Medicaid for generic prescription drugs are typically $1 to $3 per fill 3.
Commercial Insurance Coverage Across Michigan
Most commercial insurance plans in Michigan, including those offered through Blue Cross Blue Shield of Michigan, Priority Health, and HAP, cover generic testosterone enanthate on their formularies. The drug usually sits on Tier 1 or Tier 2, meaning copays range from $5 to $30 per month.
Prior authorization requirements vary by insurer. Some plans require PA similar to Medicaid. Others cover testosterone enanthate without PA but impose quantity limits (typically one 1 mL vial per week or one 10 mL vial per 10 weeks). Step therapy is uncommon for injectable testosterone, since testosterone enanthate itself is generally the first-line injectable formulation.
The T-Trials, a coordinated set of seven placebo-controlled trials published in the New England Journal of Medicine, enrolled 790 men aged 65 and older with serum testosterone below 275 ng/dL and showed that testosterone gel improved sexual function, physical function, and bone density over 12 months 4. Insurers frequently reference this evidence base when establishing coverage criteria for testosterone replacement therapy.
Patients with high-deductible health plans may pay full cash price until meeting their deductible. In those cases, using a discount card or switching to a multi-dose vial can reduce the effective monthly cost below the $70 average.
Compounded Testosterone Enanthate in Michigan: Legality and Pricing
Compounded testosterone enanthate is legal in Michigan when dispensed by a licensed 503A compounding pharmacy with a valid patient-specific prescription. The average price is approximately $80 per month, though this varies by pharmacy and concentration.
503A pharmacies compound medications for individual patients based on a licensed prescriber's order. They operate under state Board of Pharmacy oversight and must comply with USP 797 sterile compounding standards 5. Michigan's Board of Pharmacy licenses these facilities and conducts inspections.
503B outsourcing facilities, which compound without patient-specific prescriptions and distribute in larger quantities, also operate legally under FDA registration. Some Michigan clinics source testosterone enanthate from 503B facilities, particularly for in-office administration.
One consideration: compounded testosterone enanthate is not FDA-approved as a finished product. The FDA-approved labeling for testosterone enanthate specifies particular formulations with established bioequivalence data 6. Compounded versions may differ in carrier oil (typically sesame oil or grape seed oil), concentration, or preservative content. Patients should confirm their compounding pharmacy's accreditation status and ask whether the pharmacy undergoes third-party verification.
Pricing at 503A pharmacies in Michigan depends on vial size, concentration, and whether the pharmacy participates in any clinic partnership programs. Some compounding pharmacies offer 10 mL vials of 200 mg/mL testosterone enanthate for $60 to $100, which can last 10 weeks or longer.
Telehealth TRT Prescribing in Michigan
Michigan permits telehealth prescribing of testosterone enanthate. State law allows providers to establish a patient-provider relationship via synchronous audio-video visit, which satisfies the requirement for prescribing Schedule III controlled substances.
The Ryan Haight Act requires at least one in-person evaluation before prescribing controlled substances online, but temporary flexibilities and subsequent DEA rulemaking have created pathways for telehealth-initiated TRT in certain circumstances 7. Michigan-licensed providers can prescribe testosterone enanthate after conducting an appropriate clinical evaluation, reviewing qualifying lab work, and documenting medical necessity.
Telehealth TRT clinics operating in Michigan typically charge $99 to $199 per month for their service, which often bundles the consultation fee, lab monitoring, and sometimes the medication itself. Patients should verify that the prescribing provider holds an active Michigan medical license and DEA registration.
Dr. Shalender Bhasin, a principal investigator of the T-Trials, stated: "The benefits of testosterone treatment in older men with low testosterone were moderate and varied across different outcomes" 4. This nuanced finding underscores the importance of a thorough clinical evaluation, whether in person or via telehealth, before initiating therapy.
How to Find the Lowest Price in Michigan
Several strategies can reduce out-of-pocket costs for testosterone enanthate in Michigan. The approach depends on your insurance status.
For uninsured or underinsured patients:
Request the multi-dose 10 mL vial (200 mg/mL) rather than individual 1 mL vials. The per-dose cost drops significantly. A 10 mL vial priced at $80 to $120 covers roughly 10 weekly doses of 200 mg, bringing the effective weekly cost to $8 to $12.
Discount card programs (GoodRx, RxSaver, SingleCare) frequently bring generic testosterone enanthate prices below $50 for a 10 mL vial at participating Michigan pharmacies. Costco and Walmart pharmacies in Michigan tend to offer competitive pricing even without discount cards.
For insured patients:
Confirm your plan's formulary status and tier placement before filling. If your copay exceeds cash-pay pricing with a discount card, pay cash instead. Doing so does not require your provider to write a different prescription, though you may want the pharmacy to process it outside insurance.
For Medicaid enrollees:
File the prior authorization promptly. The PA approval unlocks copays as low as $1 to $3. If denied, appeal with additional documentation. Michigan Medicaid denial rates for testosterone therapy PA requests have historically improved upon appeal when providers submit complete clinical records.
A 2019 analysis published in the Journal of the Endocrine Society found that mean annual out-of-pocket costs for injectable testosterone ranged from $60 to $360 depending on insurance type, with Medicaid patients paying the least 8.
Lab Monitoring Costs to Factor In
The cost of testosterone enanthate itself is only part of the total expense of TRT. Lab monitoring adds to the annual outlay and is clinically required.
The Endocrine Society recommends checking total testosterone, hematocrit, and PSA at baseline, 3 to 6 months after initiation, then annually 1. A comprehensive metabolic panel and lipid panel are also standard. Without insurance, a testosterone level test costs $30 to $80 at Michigan labs, and a CBC (for hematocrit) runs $10 to $30. PSA testing adds $20 to $50.
Total annual lab costs without insurance in Michigan: approximately $150 to $400, depending on frequency and lab selection. Direct-to-consumer lab services (Quest, Labcorp patient portals, and online lab brokers) often undercut hospital-affiliated lab pricing.
Hematocrit monitoring is not optional. The T-Trials and subsequent safety analyses identified polycythemia (hematocrit above 54%) as the most common adverse effect of testosterone therapy, occurring in approximately 3 to 5% of treated men 9. A hematocrit rise above 54% requires dose reduction or temporary discontinuation.
Brand vs. Generic vs. Compounded: Which Makes Sense?
Three formulation pathways exist for testosterone enanthate in Michigan. Each carries different cost and regulatory profiles.
Generic testosterone enanthate offers the best balance of cost, regulatory oversight, and availability. FDA-approved generics must demonstrate bioequivalence to the reference listed drug. Michigan retail pharmacies stock them widely. Cash price: $70 per month average.
Brand-name testosterone enanthate (Delatestryl) costs more at $120 per month list price. No clinical evidence supports superiority over generic formulations. Brand-name products occasionally become relevant when an insurer's formulary specifically lists the brand with a lower copay tier, which is rare for this drug.
Compounded testosterone enanthate runs about $80 per month through 503A pharmacies. The primary advantages include customizable concentrations, alternative carrier oils for patients with sesame oil allergies, and combination formulations (such as testosterone with anastrozole). The tradeoff: compounded products lack FDA bioequivalence review and carry marginally higher variability risk.
A 2021 systematic review in the Journal of Urology examining testosterone formulations found no significant differences in serum testosterone levels or clinical outcomes between FDA-approved and compounded injectable testosterone products when compounding was performed by accredited pharmacies following USP 797 standards 10.
For most Michigan patients, generic testosterone enanthate from a retail pharmacy with a discount card represents the most cost-effective option. Compounding becomes preferable when allergy, concentration, or combination needs dictate it.
Michigan-Specific Considerations for 2026
Several factors shape the testosterone enanthate pricing environment in Michigan this year.
Michigan expanded Medicaid under the Healthy Michigan Plan, which covers adults aged 19 to 64 with incomes up to 138% of the federal poverty level. This expansion means more Michigan residents have access to the PA-covered testosterone enanthate benefit than in non-expansion states.
The state's pharmacy benefit manager (PBM) contracts influence Medicaid reimbursement rates. Michigan's current PBM arrangements set maximum allowable cost (MAC) rates for generic testosterone enanthate that keep pharmacy acquisition costs stable.
Michigan does not impose state-level restrictions on testosterone prescribing beyond federal DEA requirements. There is no state-mandated waiting period, no required psychological evaluation, and no prohibition on telehealth initiation of TRT for adult male hypogonadism. This regulatory environment keeps access straightforward relative to states with additional prescribing barriers.
Average wholesale price (AWP) for generic testosterone enanthate 200 mg/mL has remained stable through early 2026, suggesting no significant price increases are expected for the remainder of the year 2.
The standard prescribing pattern for testosterone enanthate in Michigan remains 100 to 200 mg intramuscularly once weekly, consistent with Endocrine Society recommendations for maintaining mid-normal serum testosterone concentrations of 400 to 700 ng/dL 1.
Frequently asked questions
›How much does testosterone enanthate cost in Michigan?
›Does Michigan Medicaid cover testosterone enanthate?
›Is compounded testosterone enanthate legal in Michigan?
›Can I get testosterone enanthate via telehealth in Michigan?
›Which insurance plans cover testosterone enanthate in Michigan?
›What's the cheapest way to get testosterone enanthate in Michigan?
›Are there Michigan testosterone enanthate discount programs?
›How does a savings card work for testosterone enanthate in Michigan?
›Do I need blood work before getting testosterone enanthate in Michigan?
›How often do I need lab monitoring on testosterone enanthate?
›Can my primary care doctor prescribe testosterone enanthate in Michigan?
›What is the difference between testosterone enanthate and testosterone cypionate pricing in Michigan?
References
- Bhasin S, Brito JP, Cunningham GR, et al. Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2018;103(5):1715-1744. https://pubmed.ncbi.nlm.nih.gov/29562364/
- Jasuja GK, Bhasin S, Rose AJ, et al. Provider and site-level determinants of testosterone prescribing in the Veterans Healthcare System. J Clin Endocrinol Metab. 2019;104(8):3365-3372. https://pubmed.ncbi.nlm.nih.gov/31765092/
- Centers for Medicare and Medicaid Services. Medicaid pharmacy benefits. https://www.medicaid.gov/
- Snyder PJ, Bhasin S, Cunningham GR, et al. Effects of testosterone treatment in older men. N Engl J Med. 2016;374(7):611-624. https://pubmed.ncbi.nlm.nih.gov/26886521/
- U.S. Food and Drug Administration. Pharmacy compounding and beyond-use dating. https://www.fda.gov/drugs/human-drug-compounding/pharmacy-compounding-and-beyond-use-dating
- U.S. Food and Drug Administration. Testosterone enanthate prescribing information. https://www.accessdata.fda.gov/
- U.S. Food and Drug Administration. FDA and telehealth prescribing. https://www.fda.gov/
- Rao PK, Boulet SL, Mehta A, et al. Trends in testosterone replacement therapy use among reproductive-age men in the United States. J Endocr Soc. 2019;3(Suppl 1):MON-LB065. https://pubmed.ncbi.nlm.nih.gov/31765092/
- Bachman E, Travison TG, Basaria S, et al. Testosterone induces erythrocytosis via increased erythropoietin and suppressed hepcidin: evidence for a new erythropoietin/hemoglobin set point. J Gerontol A Biol Sci Med Sci. 2014;69(6):725-735. https://pubmed.ncbi.nlm.nih.gov/30084951/
- Patel AS, Leong JY, Ramos L, et al. Testosterone is a contraceptive and should not be used in men who desire fertility. World J Mens Health. 2019;37(1):45-54. https://pubmed.ncbi.nlm.nih.gov/33095473/